These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 8237139)

  • 1. [A controlled study of the prophylactic effect of mianserin and placebo in recurrent depression].
    Kishimoto A; Mizukawa R; Hazama H; Tanaka K; Kamase H; Kunimoto N
    Yakubutsu Seishin Kodo; 1993 Aug; 13(4):225-32. PubMed ID: 8237139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value of tianeptine in treating major recurrent unipolar depression. Study versus placebo for 16 1/2 months of treatment].
    Daléry J; Dagens-Lafant V; De Bodinat C
    Encephale; 1997; 23(1):56-64. PubMed ID: 9172969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
    Dodick DW; Mauskop A; Elkind AH; DeGryse R; Brin MF; Silberstein SD;
    Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic effect of mianserin on recurrent depression.
    Kishimoto A; Mizukawa R; Matsuzaki F; Hazama H; Kamase H; Tanaka K; Kunimoto N
    Acta Psychiatr Scand; 1994 Jan; 89(1):46-51. PubMed ID: 8140906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between mianserin plasma levels and antidepressant effect in a double-blind trial comparing a single night-time and divided daily dose regimens.
    Montgomery S; McAuley R; Montgomery DB
    Br J Clin Pharmacol; 1978; 5 Suppl 1(Suppl 1):71S-76S. PubMed ID: 341947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of psychomotor performance of fluvoxamine versus mianserin in depressed patients in general practice.
    Moon CA; Jesinger DK
    Br J Clin Pract; 1991; 45(4):259-62. PubMed ID: 1810359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of mianserin add-on, on the intensity of opioid withdrawal symptoms during detoxification program--a randomized, double blind, placebo controlled, prospective study.
    Herman I; Shamir D; Bar-Hamburger R; Pick CG; Schreiber S
    Addict Behav; 2005 Jul; 30(6):1154-67. PubMed ID: 15925125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomised, double-blind, placebo-controlled trial of a herbal medicinal product containing Tropaeoli majoris herba (Nasturtium) and Armoraciae rusticanae radix (Horseradish) for the prophylactic treatment of patients with chronically recurrent lower urinary tract infections.
    Albrecht U; Goos KH; Schneider B
    Curr Med Res Opin; 2007 Oct; 23(10):2415-22. PubMed ID: 17723159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preventive treatment of recurrent essential cystitis in women. Comparative study of pipemidic acid and placebo in a daily dose of 200 mg. for 6 months].
    Ann Urol (Paris); 1989; 23(1):53-7. PubMed ID: 2729906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment strategies in patients with major depression not responding to first-line sertraline treatment. A randomised study of extended duration of treatment, dose increase or mianserin augmentation.
    Licht RW; Qvitzau S
    Psychopharmacology (Berl); 2002 May; 161(2):143-51. PubMed ID: 11981594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression--a double-blind, randomized, placebo controlled long-term trial.
    Kasper S; Volz HP; Möller HJ; Dienel A; Kieser M
    Eur Neuropsychopharmacol; 2008 Nov; 18(11):803-13. PubMed ID: 18694635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mianserin and lithium in the prophylaxis of depression.
    Coppen A; Ghose K; Rao R; Bailey J; Peet M
    Br J Psychiatry; 1978 Sep; 133():206-10. PubMed ID: 359081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative study of paroxetine and mianserin in depression in elderly patients: efficacy, tolerance, serotonin dependence].
    Daléry J; Aubin V
    Encephale; 2001; 27(1):71-81. PubMed ID: 11294041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Double-blind study of mianserin and fluoxetine in ambulatory therapy of depressed patients].
    Besançon G; Cousin R; Guitton B; Lavergne F
    Encephale; 1993; 19(4):341-5. PubMed ID: 8275922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
    Fawcett J; Barkin RL
    J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
    Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U
    J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
    Lardoux H; Maison Blanche P; Marchand X; Canler A; Rouesnel P; Bleinc D; Péraudeau P; Scheck F
    Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):469-79. PubMed ID: 8952741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in the ICD-10 diagnostic subtype of depression in bipolar disorder compared to recurrent depressive disorder.
    Kessing LV; Jensen HM; Christensen EM
    Psychopathology; 2008; 41(3):141-6. PubMed ID: 18187963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of mirtazapine and fluoxetine in the treatment of major depressive disorder: a double-blind, randomized trial.
    Amini H; Aghayan S; Jalili SA; Akhondzadeh S; Yahyazadeh O; Pakravan-Nejad M
    J Clin Pharm Ther; 2005 Apr; 30(2):133-8. PubMed ID: 15811165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.